FINWIRES · TerminalLIVE
FINWIRES

CVS Health在第一季度业绩超预期后上调了2026年业绩展望。

By

-- CVS Health (CVS) 在公布优于预期的第一季度业绩后，上调了全年盈利预期，主要得益于其医疗保健福利业务的改善。 该公司将2026年调整后每股收益预期从之前的7美元至7.20美元上调至7.30美元至7.50美元。FactSet 的市场共识预期为7.16美元。 首席财务官布莱恩·纽曼在财报电话会议上表示：“我们还将全年经营活动现金流预期上调至至少95亿美元，这反映了基本面的改善，主要与医疗保健福利业务的营运资本有关。” 该股周三上涨7.3%，今年以来累计上涨9.1%。 CVS 维持了其医疗福利比率预期，该比率代表保费中用于医疗福利的百分比。 纽曼表示：“在更清晰地了解药房和消费者健康业务板块的医疗成本趋势发展情况之前，我们将继续对医疗成本趋势保持谨慎和审慎的态度。” 第一季度，调整后每股收益从去年同期的2.25美元增至2.57美元，营收增长6.2%至1004.3亿美元。华尔街此前预期每股收益为2.18美元，营收为949.7亿美元。 医疗保健福利业务板块的销售额增长3.3%至359.7亿美元。纽曼表示：“这一增长主要得益于政府业务，但部分被我们2026年退出个人医保交易市场业务所抵消。” 医疗服务业务板块的营收增长11%至482.4亿美元，而药房和消费者健康业务板块的营收基本持平，为319.9亿美元。

Price: $86.61, Change: $+5.92, Percent Change: +7.34%

Related Articles

Mining & Metals

Stifel Canada on Cargojet's "Solid" Q1

Cargojet (CJT.TO) reported solid first-quarter results despite the macro volatility, underpinned by resilient domestic network performance and growth in new charter business in South/Central America, notes Stifel Canada.Analyst Daryl Young, who is maintaining a buy rating and $120.00 price target on the company's shares, notes that, at first look, Cargojet's adjusted EBITDA of $81.9 million was 4.9% above consensus.Management provided a constructive outlook, with the domestic network performing well through April, while the new charter customers/routes are expected to smooth traditional seasonality across the year.Revenue associated with the grounding of the MD-11 jets last November is expected to continue through the third quarter of this year. The international aircraft, crew, maintenance and insurance (ACMI) business remains slow, but appears to have found a new run-rate for the north/south routes (east/west routes will still take time to recover), Young adds."Overall, we continue to think that CJT is doing a good job managing through the current depressed environment, with its fundamental results and share price poised to see upside as tariff/trade overhangs eventually fade."Price: $82.17, Change: $+4.47, Percent Change: +5.75%

$CJT.TO
Research

Research Alert: CFRA Maintains Hold Opinion On Lucid Group Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target to $6 from $10. Following a weaker-than-expected Q1 earnings release, we are maintaining a Hold opinion on LCID shares. We revise our adjusted EPS estimates to -$12.00 from -$12.70 for '26 and to -$11.10 from -$11.45 for '27. LCID posted Q1 adjusted EPS of -$2.82 vs. -$2.04, well short of the -$2.30 consensus. Revenue rose 20% to $282.5M ($76.0M below consensus) in Q1, led by higher prices, as total vehicle sales fell 1% to 3,093 units. In the release, LCID did not provide any update regarding prior 2026 vehicle production guidance of 25K-27K units (an implied increase over the 17,840 units produced in 2025). In our view, LCID's accelerating cash burn and rising inventories suggest ongoing risks. The company's ability to achieve sustainable growth while managing its substantial cash requirements remains the critical challenge as it seeks to establish a viable position in the competitive luxury EV market; however, a $1.5B capital raise last month helps extend its liquidity runway.

$LCID
Mining & Metals

RBC Lowers Colliers International Group's Price Target to US$155.00 From US$160.00, Maintains Outperform Rating

RBC Capital Markets maintained its outperform rating on the shares of Colliers International Group (CIGI.TO, CIGI) and lowered its price target to US$155.00 from US$160.00 after the company reported its first-quarter financial results.RBC characterized Q1 as "top-line strong but bottom-line wobbly.""Overall AEBITDA margin declined 67 bps to 9.5%, caused by: 1) CIGI has been investing in recruiting and IT investments to enable AI efficiencies within CRE, 2) Outsourcing had slower growth, 3) Lower utilization in residential development and telecom end markets in Engineering, 4) Higher than expected tax rate in Europe, 5) Integration under Harrison Street platform in IM, which has been well articulated in the past," stated RBC.While 2026 guidance was maintained, it relies on a strong H2, said RBC. CM and leasing appear on track to deliver "strong revenue growth", 25% expected for CM and 8% for leasing in 2026, which RBC expects to more fully flow through to EBITDA in H2, as it did last year. Europe and APAC "could be slowing somewhat" from the Iran war but NA "remains strong notwithstanding rate rise," it further stated."Given macro uncertainties and lingering AI impact overhang where one is 'guilty until proven innocent', CIGI's price action today suggests that the market has no patience for wobbly quarters nor backend-loaded guidance," said RBC in a note dated May 5, 2026.RBC continues to believe that for "patient investors", CIGI offers "good value" even under RBC's "more conservative" 2026 estimates at 13x AEPS and 10.5x AEBITDA."Our new PT of (US)$155 (-3%) is based on forward AEBITDA multiple of 12.5x, reflecting 11x for CRE, 12x for Engineering and 15x for IM. Maintain OP," added RBC.Price: $137.23, Change: $+5.09, Percent Change: +3.85%

$CIGI$CIGI.TO